surmount tirzepatide trials SURMOUNT-5: shows superior weight loss over semaglutide Tirzepatide not linked to increased

Renewing the skin helps remove dead skin and promotes new skin cells to rise to the surface

propensity-matched 118,993 GLP-1 RA users to 118,993 non-users in the TriNetX network and found a modest but statistically robust 2123% higher hazard of new-onset hypersomnolence at 1 and 5 years

McKinsey Health Institute

60% Percent of ASO members achieving diabetes reversal More than half of ASO patients who are with Virta for one year achieve diabetes reversallowering blood glucose below the diabetes threshold while removing all diabetes-specific medications

GLP-1 agonist drugs enhance this function of GLP-1, achieving weight control effects by suppressing appetite

In addition to conducting regular medication reconciliation to identify what prescription medications, non-prescription medications, and supplements a patient is taking, take steps to build trust and rapport